Pharma OGZ SRL SRL
1.8 FTEPharma OGZ SRL reported total assets of €1.35m at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Oct 2026), with 1.8 full-time equivalent.
The score of Pharma OGZ SRL shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +36 % Total assets +1294 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma OGZ SRL's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Oct 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
Pharma OGZ SRL's financial analysis
- Solvency7.0%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma OGZ SRL
Pharma OGZ SRL's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0792.333.711
- VAT number
- BE0792333711
- Peppol
- Registered · 0208:0792333711 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Oct 2022
- Registered office
- 1020 Brussels
- Size
- Micro · 1.8 FTE
- Latest accounts
- 2025 · filed on 15 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma OGZ SRL (SRL) has been based in Brussels since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 19,999 € and equity of 94,040 €; its revenue is not published. With 1.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 7.0%, below the median of its sector (37.6%).
Companies similar to Pharma OGZ SRL
Companies in the same business, of comparable size and area, outside its group.
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- DE Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Zuiderkruis Retail sale of pharmaceutical products Antwerp · balance sheet €1.35m
- Mast & CO Retail sale of pharmaceutical products Merchtem · balance sheet €1.36m
- Decupere Farma Retail sale of pharmaceutical products Zonnebeke · balance sheet €1.33m
- Apogrez Retail sale of pharmaceutical products Grez-Doiceau · balance sheet €1.37m
- Geerts Farma Retail sale of pharmaceutical products Vilvoorde · balance sheet €1.38m
Frequently asked questions about Pharma OGZ SRL
What is the revenue of Pharma OGZ SRL?
Pharma OGZ SRL files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma OGZ SRL?
In Belgium, the VAT number is the company number prefixed with BE: BE0792333711 for Pharma OGZ SRL, if the company is VAT-registered. Its company number (CBE) is 0792.333.711.
Where is the registered office of Pharma OGZ SRL?
According to the CBE register, the registered office of Pharma OGZ SRL is in 1020 Brussels.
What is the equity of Pharma OGZ SRL?
At the close of the 2025 financial year, the equity of Pharma OGZ SRL amounts to 94,040 €, a solvency of 7.0% of total assets.
How many people work at Pharma OGZ SRL?
1.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma OGZ SRL?
The register lists 1 active mandates at Pharma OGZ SRL. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma OGZ SRL
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →